Pharmaceutical

Current location:Home > Pharmaceutical

Ceritinib (LDK378)

  • CAS No.: 1032900-25-6
  • Purity: 99%
Contact us

Manufacturer supply Ceritinib (LDK378) 1032900-25-6 with sufficient stock and high standard We provide high quality Ceritinib (LDK378) (CAS 1032900-25-6), at a very affordable prices to our customers.

1.What is the Ceritinib (LDK378) ?

Ceritinib (previously LDK378l, brand name Zykadia; Novartis Pharmaceuticals) is an oral small molecule tyrosine kinase inhibitor of ALK [87]. Preclinical studies suggested that it would inhibit ROS1 as well [88, 89].

Ceritinib (Zykadia(R), Novartis), approved in 2014, was developed as a second-generation ALK inhibitor for patients with NSCLC who have developed crizotinib resistance. Ceritinib addresses two of the most common ALK mutants that lead to crizotinib resistance, L1196M andG1269A, but is ineffective for G1202R and F1174C variants of ALK.

5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine, is a Anaplastic lymphoma kinase (ALK) inhibitor.

2.What is the CAS number for Ceritinib (LDK378) ?

The CAS number of Ceritinib (LDK378) is 1032900-25-6.

More information of Ceritinib (LDK378) 1032900-25-6 are:

CAS?Number

1032900-25-6

Density

1.251±0.06 g/cm3(Predicted)

Boiling Point

720.7±70.0 °C(Predicted)

PSA

116.85000

LogP

7.26640

Pka

10.16±0.10(Predicted)

3.What is the molecular formula of Ceritinib (LDK378) ?

The chemical formula of?Ceritinib (LDK378) is C28H36ClN5O3S which containing 28 Carbon atoms,36 Hydrogen atoms,1 Chlorine atoms,5 Nitrogen atoms,3 Oxygen atoms and 1 Sulfur atoms,and the molecular weight, and the molecular weight of Ceritinib (LDK378) is 558.145

4.What is Ceritinib (LDK378)(1032900-25-6)used for?

Ceritinib (previously LDK378l, brand name Zykadia; Novartis Pharmaceuticals) is an oral small molecule tyrosine kinase inhibitor of ALK [87]. Preclinical studies suggested that it would inhibit ROS1 as well [88, 89].

Relevant articles related to Ceritinib (LDK378):

Article

Source

Synthesis and anticancer activities of ceritinib analogs modified in the terminal piperidine ring

Wang, Peng,Cai, Jin,Chen, Junqing,Ji, Min

, p. 1 - 8 (2015)

Preparation method of ceritinib

-

Paragraph 0040-0054, (2020/07/24)

5.Manufacturer supply Ceritinib (LDK378) 1032900-25-6 with sufficient stock and high standard

ZHUHAI JC BIOLOGICAL TECHNOLOGY CO.,LTd is a quality supplier of Ceritinib (LDK378). Our main goal is customer satisfaction. Contact us to negotiate the best price for your business on Ceritinib (LDK378) 1032900-25-6.

WANT TO PURCHASE
*Product Name
CasNo
Purity
Quantity
Company name
*Email
*Other Description
*Verification code:
ITEMS MARKED WITH * ARE MANDATORY
Submit now